RENAL INSUFFICIENCY, CHRONIC

This study tested whether dapagliflozin, a drug used for diabetes, could improve blood vessel function in 32 adults with chronic kidney disease (CKD). Participants took the drug for 12 weeks, and researchers measured changes in artery health using ultrasound and other tests. The …

This study tested a medicine called patiromer in 262 Chinese adults with chronic kidney disease and high potassium levels. The goal was to see if patiromer could safely lower potassium and help patients stay on important heart and kidney medications. Participants first received p…

This early-stage study tested a single dose of the investigational drug Gemini in 40 adults with stage 3 or 4 chronic kidney disease. The main goal was to check if Gemini is safe and tolerable compared to a placebo. Researchers also measured how the drug moves through the body an…

This study tested a smartphone app called SMART-HABITS in 47 adults with chronic kidney disease and high blood pressure. The app provided reminders, feedback, and educational resources to help patients track their blood pressure and steps. The goal was to see if people would use …

This study looked at whether giving free produce vouchers to adults with chronic kidney disease who also have trouble affording food can improve their health and quality of life. One hundred participants were randomly assigned to receive vouchers every two weeks for six months or…

This study tested a program that sends text reminders and uses social support and game-like features to encourage people with chronic kidney disease, diabetes, and high blood pressure to check their blood pressure regularly. 70 adults from a University of Pennsylvania kidney clin…

This study checked how many Brazilian adults with risk factors like diabetes or high blood pressure have undiagnosed chronic kidney disease (CKD). Over 8,000 people were tested with a simple finger-stick device that measures creatinine. Those with abnormal results were referred f…

This study looked at 268 adults with kidney failure who were on dialysis. Researchers used portable heart monitors to track heart rhythm problems and blood sugar changes. The goal was to see how these issues relate to the risk of heart-related death or other serious heart events …

This study tested how well a once-daily form of metformin (metformin XR) controls blood sugar over 24 hours in people with type 2 diabetes and mild to moderate chronic kidney disease (CKD stages 1-3). Twelve participants took the drug while their blood sugar was continuously moni…